Viewing Study NCT06635889



Ignite Creation Date: 2024-10-26 @ 3:42 PM
Last Modification Date: 2024-10-26 @ 3:42 PM
Study NCT ID: NCT06635889
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-10-08

Brief Title: Intravesical Bupivacaine on Post-Operative Ureteroscopy Pain
Sponsor: None
Organization: None

Study Overview

Official Title: Double-Blind Randomized Placebo Controlled Trial of Intravesical Bupivacaine on Post-Operative Ureteroscopy Pain
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Post-operative pain and lower urinary tract symptoms are common following ureteroscopy in the treatment of stone disease The use of bupivacaine as a topical pain medication is used routinely for other urologic procedures however to date there are no studies that have rigorously investigated the effect of instilling bupivacaine in the bladder following ureteroscopy

This is a randomized study that will investigate the effect of instilling bupivacaine in the bladder following routine ureteroscopy laser lithotripsy and ureteral stenting in the treatment of stone disease Compared to a placebo of Normal Saline our study hypothesizes that administration of topical bupivacaine in the bladder will decrease post-operative pain and lower urinary tract symptoms while improving quality of life in the early post-operative period
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None